Topic: contract research organizations
PPD, which is going public (again) after years of being private, is ramping up its clinical research units (CRUs).
Biopharma and CRO veteran Beatrice Setnik, Ph.D., has become the new chief scientific officer at Canadian clinical research firm Altasciences.
Parexel has been on a recruiting spree of late, delving into FDA to beef up its regulatory offerings. Now, it’s turned to fellow biopharma services provider BioClinica for a more digital role.
PPD is further boosting its real-world data offerings with its subsidiary Evidera snapping up Medimix.
Icon is at it again as it snaps up a majority stake in MeDiNova Research with an option to buy out the remaining shares penned into the deal.
Biotech-CRO hybrid Evotec is continuing its buying and collaborating strategy with its acquisition of U.S. biologics company Just Biotherapeutics.
To make clinical trials more affordable and lead to the results needed for approval, MarkLogic has set up a new hub designed to do just that.
WuXi AppTec’s CRO arm WuXi Clinical will subsume Pharmapace into its business as the China giant looks to up its trial services in biometrics.
LabCorp’s CRO business Covance will boost its nonclinical services business as its parent company buys out the segment from Envigo.
Philippa Marshall, M.D., has been hired as Worldwide Clinical Trials’ new VP for scientific solutions in immune-mediated inflammatory disorders.